Hugh Gloster, MD
MOHS-Micrographic Surgery · Cincinnati, OHNPI 1902850126
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $231 of the $330 with a category attached, or 70.0%. 5 manufacturers reported payments, led by Genentech USA, Inc. at 51.2% of the total. Reporting peaked in 2019 at $169 and has fallen 82.6% since, to $29 in 2024. That places this record below the midpoint for mohs-micrographic surgery clinicians in OH, where the typical reported total is $1,196.
Across 7 payments — averaging $47.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$169
- Sanofi$93
- Lilly USA, LLC$29
- Organogenesis Inc.$19
- Galderma Laboratories, L.p.$19
What the payments were for
- Food & beverage$23170%
- Education$9930%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 3 | $169 |
| Sanofi | 1 | $93 |
| Lilly USA, LLC | 1 | $29 |
| Organogenesis Inc. | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $19 |
How this compares
$330 in reported general payments places this provider in the 20th percentile of 35 mohs-micrographic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 11 | $988 |
| Mupirocin | 163 | $988 |
| Imiquimod | 17 | $494 |
| Gentamicin Sulfate | 19 | $468 |
| Doxycycline Hyclate | 16 | $133 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $42 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Cincinnati
- Kyle RismillerCincinnati$656
- Jennifer WalkerCincinnati$18
- Jorge Garcia ZuazagaConcord Township$149K
- Morgan HottWarren$16K
- Jennifer PopovskyMedina$15K
- Justin WoodhouseMayfield Heights$7K
- Mihir ShahWestlake$5K
- Allison MoosallyFairlawn$5K
- Kathleen NemerAthens$3K
- Abdel Kader TalPerrysburg$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.